Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The paper by Fliser et al. [1], which has been published in this issue of Nephrology Dialysis Transplantation, was aimed at assessing the effect of a low dose of the continuous erythropoiesis receptor activator (CERA) on the rate of decline of kidney function in patients with moderate chronic kidney disease (CKD) [estimated glomerular filtration rate (eGFR) between 30 and 59 mL/min/1.73 m2].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
